Goldman Sachs is reporting the healthcare sector looks rocky ahead, according to a CNBC report.
Here are five reasons why:
1. October tends to see more volatility in the broader market.
2. There are big healthcare and biotech conferences in October, in addition to analyst meetings.
3. October brings another earnings report, which could signal turbulence.
4. The upcoming presidential debates ahead of the election could affect the healthcare space, as healthcare is one of the big issues in the election. Regardless of who wins the presidency, there will likely be changes in the healthcare sector within the first 100 days of the new presidency, which could affect healthcare companies' pricing power.
5. There is public dissatisfaction with pharmaceutical prices today. Sudden price increases, including those for EpiPen most recently, have come under fire.